Komori
C'Bon Cosmetics (4926) · RiskWorsened

Decline in Share Prices of Held Investment Securities

First written in FY2017. 4 of 12 entries say "Worsened", first in FY2018. Latest entry: FY2026.

12entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2019-Q3 – FY2020-Q3MitigatedFY2024 – FY20252017: 120172018: 120182019: 220192020: 220202021: 120212022: 120222023: 120232024: 120242025: 120252026: 12026
Same theme, other companies
Valuation Losses Due to Declines in the Market Value of Securities HeldA theme 226 companies write about · 223 as a headwind · 3 as a tailwind

C'Bon Cosmetics moved to the "Worse" side of this theme in 2026, 7 years after the typical company in this theme (2019).

The whole theme swung hardest in 2019: 69 of 144 companies on the "Worse" side.

20 other companies' latest entry also says "Worsened".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 198 companies compared. The sentences above are computed from all 198.Comparing 200 of the theme's 228 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026WorsenedAnnual report

    「The shares other than unlisted shares comprise 8 issues, with a total balance-sheet carrying amount of ¥323.139 million.」

    The balance of investment securities exposed to the risk of fluctuations in market prices increased from 9 issues with a balance of ¥317.142 million in the previous fiscal year to 8 issues with a balance of ¥323.139 million.
  2. FY2025MitigatedAnnual report

    「The shares other than unlisted shares comprise 9 issues, with a total balance-sheet carrying amount of ¥317.142 million.」

    Investment securities exposed to the risk of fluctuations in market prices decreased from 10 issues with a balance of ¥331.110 million in the previous fiscal year to 9 issues with a balance of ¥317.142 million.
  3. FY2024MitigatedAnnual report

    「The shares other than unlisted shares comprise 10 issues, with a total balance-sheet carrying amount of ¥331.110 million.」

    The balance of investment securities exposed to the risk of fluctuations in market prices decreased from ¥341.683 million in the previous fiscal year to ¥331.110 million.
  4. FY2023WorsenedAnnual report

    「The shares other than unlisted shares comprise 10 issues, with a total balance-sheet carrying amount of ¥341.683 million.」

    The balance of investment securities exposed to the risk of fluctuations in market prices increased from ¥317.108 million in the previous fiscal year to ¥341.683 million.
  5. FY2022MitigatedAnnual report

    「The shares other than unlisted shares comprise 10 issues, with a total balance-sheet carrying amount of ¥317.108 million.」

    The balance of investment securities decreased from ¥375.971 million in the previous fiscal year to ¥317.108 million, reducing the balance exposed to fluctuations in market prices.
  6. FY2021WorsenedAnnual report

    「Investment securities 344.160 375.971」

    The balance of investment securities increased from ¥344.160 million in the previous fiscal year to ¥375.971 million, expanding the balance exposed to fluctuations in market prices, including share prices.
  7. FY2020MitigatedAnnual report

    「Decrease in investment securities (down ¥75.854 million from the end of the previous consolidated fiscal year)」

    The balance of investment securities decreased from ¥420.014 million to ¥344.160 million, reducing the Company's exposure to valuation losses arising from declines in share prices and other factors.
  8. FY2020-Q3Decrease in valuation differences on other securitiesAnnual report

    「The valuation difference on available-for-sale securities was negative ¥16.447 million.」

    The valuation difference on available-for-sale securities decreased by ¥16.447 million during the cumulative third quarter of the consolidated fiscal year. The text does not explicitly state a direct causal relationship with the decline in share prices.
  9. FY2020-Q2Decrease in valuation differences on other securitiesAnnual report

    「The main factor was a ¥12.796 million decrease in the valuation difference on available-for-sale securities from the end of the previous consolidated fiscal year.」

    The ¥12.796 million decrease in the valuation difference on available-for-sale securities from the end of the previous consolidated fiscal year was identified as a factor contributing to the decline in net assets. The text does not explicitly state a direct causal relationship with the decline in share prices.
  10. FY2019-Q3Decrease in valuation differences on other securitiesAnnual report

    「The main factors were decreases in retained earnings, down ¥59.682 million from the end of the previous fiscal year, and the valuation difference on available-for-sale securities, down ¥66.849 million from the end of the previous fiscal year.」

    The decrease in the valuation difference on available-for-sale securities of ¥66.849 million was identified as a factor contributing to the decline in net assets. The text does not explicitly state a direct causal relationship with the decline in share prices.
  11. FY2018WorsenedAnnual report

    「As of the end of the fiscal year ended March 2018, the balance of investment securities held by the Company was ¥572.772 million, equivalent to 4.9% of total assets.」

    The balance of investment securities increased from ¥396.855 million, or 3.5% of total assets, in the previous fiscal year to ¥572.772 million, or 4.9%.
  12. FY2017First statedAnnual report

    「As of the end of the fiscal year ended March 2017, the balance of investment securities held by the Company was ¥396.855 million, equivalent to 3.5% of total assets. If market conditions for shares and bonds decline significantly in the future, valuation losses may arise on the securities held by the Company, potentially affecting its financial position and operating results.」

    The risk of valuation losses arising from declines in the market prices of investment securities was disclosed for the first time, including the balance and its ratio to total assets.
Moved together

"Improvement in net sales, ordinary profit, and ordinary profit margin" moved the same way as this thread, in the same document, in 5 of its 12 moves.

554444★123456
  1. ★This thread
  2. 1Improvement in net sales, ordinary profit, and ordinary profit margin5×
  3. 2Turnaround of Existing Stores5×
  4. 3Expansion of product lines, including natural and anti-aging care4×
  5. 4Reform of Sales Methods for New Customers4×
  6. 5New Customer Acquisition Through Online Outreach and Mail-Order Sales4×
  7. 6Research and Development Center and Open Innovation4×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
C'Bon Cosmetics's next results are scheduled for 2026-11-05. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Decline in Share Prices of Held Investment Securities | C'BON COSMETICS Co.,Ltd. (4926) | Komori